Foundations Investment Advisors’s Medicus Pharma MDCX Stock Holding History

Foundations Investment Advisors’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.91K	Buy	+11,000	New	+$3.9K	﹤0.01%	1202

Other funds holding MDCX

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MHC

May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Foundations Investment Advisors's MDCX Position: Q2 2026 in Review

Foundations Investment Advisors opened a new position in Medicus Pharma (MDCX) in Q2 2026: 11,000 shares worth $4.91K. The stake represents ﹤0.01% of the portfolio and ranks #1202 among its holdings.

23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

Foundations Investment Advisors held 11,000 shares of Medicus Pharma worth $4.91K as of Q2 2026.
Medicus Pharma was a new Foundations Investment Advisors position in Q2 2026.
Medicus Pharma made up ﹤0.01% of Foundations Investment Advisors's portfolio in Q2 2026, its #1202 holding.
23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.